Novartis today announced results from an updated analysis of the pivotal Phase III NATALEE trial of Kisqali ® (ribociclib) that underscore the extended efficacy beyond the duration of treatment in ...
Under the agreements, AmMax and MD Anderson will build upon preclinical discoveries made by MD Anderson researchers to evaluate the potential for AMB-066, which targets colony stimulating factor 1 ...
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a Tennessee-based specialty pharmaceutical company, saw its stock price surge by a remarkable 95.96% to $2.43 in Tuesday’s premarket trading session.
Galderma should launch its skin drug Nemluvio, to treat prurigo nodularis in the U.S. and Europe; Ipsen will bring its rare liver disease drug Iqirvo to market; and Sandoz is set to introduce a ...